Investing in theadaptive data layerof biotech.

We back US-based teams leveraging proprietary data to build scalable products and services, and work closely with teams as trusted advisors.

Stage
Pre-seed, Seed, Series A
Focus
AI, biology, data
Home base
Nashville, TN
Platform
Frontiers Summit
Our worldview

Breakthroughs shouldn’t take a generation to reach the people who need them.

That timeline is already shrinking. AI, proprietary biological data and new computing tools are compressing decades of discovery into months, and the tools making it possible are being built today.

Models keep getting better, but they are only as good as the data they learn from. Tools that make biological data easier to interpret, and analysis more precise, are the enabling layer for every model improvement to come.

How we get there

Our thesis

Phase Capital invests in technology-first, revenue-generating companies (pre-seed – Series A) at the intersection of AI, biology, and proprietary data. We focus on the adaptive data layer of biotech: platforms that continuously generate proprietary biological data, building the foundational infrastructure from which future therapies, diagnostics, industrial biology, and entirely new categories of innovation will emerge.

How we help

Accelerating tech bio companiesOne phase at a time.

“Phase Capital has been our most helpful investor.”
Current portfolio company
01For the company

We surround our companies with the downstream capital partners, strategics, and commercial relationships that accelerate revenue and impact.

02For the founder

We put our founders in the rooms and on the stages where the right partners find them.

We do both through our annual Frontiers Summit and focused gatherings throughout the year.

The platform

Frontiers Summit

The Frontiers Summit is our seminal annual event, convening thought-leaders and stakeholders from every spoke of the innovation flywheel. The Summit creates support and partnership opportunities and strengthens the broader national techbio ecosystem. Every attendee is invited into the Frontiers Network, which keeps those connections going between events.

A panel discussion on stage at Frontiers Summit 2026
Attendees connecting at a Frontiers Summit reception
Gatherings throughout the year
San FranciscoNew York CityChicagoNashville
All events

Perspectives

White paperFrontiers Summit 2026
Partnering with cancer centers and health systems across the innovation flywheel.
February 19–20, 2026 · Nashville, TNRead the white paper
On stage
SynBioBeta · May 4–7, 2026 · San Jose, CA

Biology Without Cells: The Rise of Cell-Free Biomanufacturing

Kavya Sharman led the panel.

Details
BioCentury Grand Rounds · June 3–5, 2026 · Seattle, WA

DNA Typewriter

Kavya Sharman joined as the voice on venture capital’s role in translating groundbreaking research.

Details

Leadership team

Kavya Sharman

Kavya Sharman, PhD

Managing Partner
LinkedIn
Kristen Johns

Kristen Johns, JD

Partner
LinkedIn
Abigail Harris

Abigail Harris

Analyst
LinkedIn
Kristan Lemmons

Kristan Lemmons

Executive Assistant
LinkedIn
Elena Solopova

Elena Solopova

Senior Venture Fellow
LinkedIn

Advisors

Laurel Graefe

Laurel Graefe

Navora Advisory
LinkedIn
Ronnie Andrews

Ronnie Andrews

Bethesda Group Advisors
LinkedIn

The Phase Capital team is complemented by an extended network of seasoned advisors and operators who engage with companies in fractional and advisory-board capacities.

Events

Upcoming
April 15-16, 2027Nashville, TN

Frontiers Summit 2027

The annual Frontiers Summit returns in 2027.

Details
Recent
October 7, 2026San Francisco, CA

Tech Bio Frontiers Popup at SF Tech Week

A Phase Capital gathering for founders, investors, and operators during SF Tech Week by a16z.

Details

Get in touch.

Reach out about the fund, Frontiers, or working together.

admin@phasecapital.co